{"name":"Invivyd, Inc.","slug":"invivyd-inc","ticker":"","exchange":"","domain":"invivyd.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"VYD2311-MD","genericName":"VYD2311-MD","slug":"vyd2311-md","indication":"Prevention of COVID-19","status":"phase_3"},{"name":"VYD222 (pemivibart)","genericName":"VYD222 (pemivibart)","slug":"vyd222-pemivibart","indication":"Treatment of mild to moderate COVID-19","status":"phase_3"},{"name":"VYD2311-SD","genericName":"VYD2311-SD","slug":"vyd2311-sd","indication":"Prevention of COVID-19 disease caused by SARS-CoV-2 virus","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"VYD222","genericName":"VYD222","slug":"vyd222","indication":"Other","status":"phase_2"},{"name":"VYD2311","genericName":"VYD2311","slug":"vyd2311","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"VYD2311-MD","genericName":"VYD2311-MD","slug":"vyd2311-md","phase":"phase_3","mechanism":"VYD2311-MD is a monoclonal antibody that targets the SARS-CoV-2 spike protein.","indications":["Prevention of COVID-19"],"catalyst":""},{"name":"VYD222","genericName":"VYD222","slug":"vyd222","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"VYD222 (pemivibart)","genericName":"VYD222 (pemivibart)","slug":"vyd222-pemivibart","phase":"phase_3","mechanism":"VYD222 (pemivibart) is an investigational antiviral medication that works by inhibiting the replication of SARS-CoV-2.","indications":["Treatment of mild to moderate COVID-19"],"catalyst":""},{"name":"VYD2311","genericName":"VYD2311","slug":"vyd2311","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"VYD2311-SD","genericName":"VYD2311-SD","slug":"vyd2311-sd","phase":"phase_3","mechanism":"VYD2311-SD is a COVID-19 vaccine.","indications":["Prevention of COVID-19 disease caused by SARS-CoV-2 virus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQX29PTXdOWFJNS1duZWVZbE5nNndRUlBDZjJPVkJoZmdDTTZqdVR5ZVQ1NDdpU29kaERrc28yMEV2VEVhWDNqbEZxRHFEVFZHbXV0S0dRLVdVclAxQUQ2eFhtYTFmQ09JakZzZVdQeTBpaHRTa3dvSHMwYU5ROEt0VGJWalR1ZWJHN1J6b3IxNUc0UWdpWDVVWHdkQV9LMEg1M3MxTnZnSlFBNTIyN1Jvcg?oc=5","date":"2026-04-08","type":"pipeline","source":"Fierce Pharma","summary":"Invivyd launches ‘Antibodies for Any Body’ campaign with Olympic skier Lindsey Vonn - Fierce Pharma","headline":"Invivyd launches ‘Antibodies for Any Body’ campaign with Olympic skier Lindsey Vonn","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-27","type":"pipeline","source":"simplywall.st","summary":"Exploring Three High Growth Tech Stocks In The US Market - simplywall.st","headline":"Exploring Three High Growth Tech Stocks In The US Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNN1NNaEZjZWxtQUxveDZVcUNCM2NPeFZfWFljNVpZRHNKeWZ6Z05HbDdCeVd0TmpWNW42Sy1PcDZVTnNPQ3hiSW8yVWFXeDJNMDgxeVB1d3hUVDJ3TFlpZ1hEVXVSalY0SUg4UEhYRnRvR01zcnk0RGdBZFJDbHh0bjR5UG4xRkswWUJlY3NuUFNZWXkyZWYxMkNR?oc=5","date":"2026-03-05","type":"pipeline","source":"Contract Pharma","summary":"Invivyd Names Michael Mina Chief Medical Officer - Contract Pharma","headline":"Invivyd Names Michael Mina Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPZjNYMGZjbXhtdEd0ZlF6YmhxenFZRm1HTVJuM2MtTkYzUEVUWE90bV9CTldNZWxpa0MteTlzTDFkQlpHWDR4ME4xaWMxVS0wQUxBLVdmUEhPdWVtZld0MXllUFJlQk8tTkRnd3c0a1BnaWdIbzZZUTJ1d2RlWkJ2ZndOQVBuSkQ0c0tWOEQ3RUlEZUhfU2l3VndNMFVWVGhQbktMM1RkRXZ4UmdNcWJ6X0kwQTRLMm9IaWFwd1BDSXBtTjVCWlhrdzB2RHJDaEtxM3QxamlST2E3UGRtSUhicTdWSWluSTVQb0t4RUtn?oc=5","date":"2026-02-04","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOOW5nUlhRQ3JVenY3LUxBeWExQmw4LV9URDczRmlPZDIyQ1U4ZlNZNlE5WWYtMHVMTU9LcjZhS0hZOE82SWM1dXV3Tlh0T0lHbDRBSUd3dWJjOTBsWHIyTXlQZjVsa0FKc3lpazlNUzc0NkY4NFk0c3EyUXlwSkc3dlFGLTBwMlpRelJXR3BLS1kxcFJNWmlBcXVKNVRHd3REUTkxOXlCakF6c3ctdW1GQzBJWXc4Rm5OaWFFYjktZExpa3JLY1NiZXdyZEJ1eVF0LVQyLXlmRjBDZHZidjljeXBtYTk0SXAyMVR3S1Vob2hRa3lDc012NTlqUG1nUlhK?oc=5","date":"2026-01-23","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Invivyd (IVVD), Alignment Healthcare (ALHC) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Invivyd (IVVD), Alignment Healthcare (ALHC)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNUjluazQwbFpWTThqclZQWDJteEpBdUVRaXBaajRTYVZnOW1DY0dvaU5SNWtpczh2SlZSd1U4YzJPNGpySUlnNVE3cG1hWFZ0SXVKREVmWjRscnZ3aE41WldOR0VhaW5vR2F3am90azl3Ylphd1VSYjlldVBDcGxpcDUwZzdTQnN1aXdiOXRiQVhka1JzTDJWVDVhRUdERGc?oc=5","date":"2026-01-22","type":"pipeline","source":"Fierce Pharma","summary":"Invivyd teams up with Olympic skier Lindsey Vonn for antibody education - Fierce Pharma","headline":"Invivyd teams up with Olympic skier Lindsey Vonn for antibody education","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-23","type":"pipeline","source":"simplywall.st","summary":"Is Invivyd’s (IVVD) Index Debut Quietly Reframing Its Long-Term Biotech Positioning? - simplywall.st","headline":"Is Invivyd’s (IVVD) Index Debut Quietly Reframing Its Long-Term Biotech Positioning?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNd1l4akFNMjQtcjY0RzdrOW05NkJIX1E2R3Zuak12NFlCU2hoNFlGUC14ekdQT3p5akVDbE05RlcwQ05NTGE5Vy1rM3JiZTdWSFBBNEJXOW1CaHIxcFBoQ083YlpybUF3cFJKeE91RGdxcWV1TlIwUXlOMnJUZFh4eXZxcEVjTXBVQUFETVI5dXNBNHdWMWpVVXFTWWJ3RUxkMzBJQ0J2cUFmZzB5aFpldEtsUHBQby03MU9UZzBRcWlRSURvSXRxZy1IVVFxWFJJRWdSWTFEWkRxamdHVFdLYzNOZnZLODBUZTVRQlAwOFVyV25ITlVR?oc=5","date":"2025-11-18","type":"pipeline","source":"Benzinga","summary":"Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga","headline":"Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNN0FQcjdnYjl6Sm01aTV2Y1BWSFdPdnBGWVdxdWF2WUZwbllpVE8yOTVJLVo3LWNwQXdueWRrVFdBdklxRTlRQXE3N1RLSC1jazhUY05ZVXRkbE5hX2hZd0ljSE9RMWJtcE1IdGJzZ2FndzBULWUwMnFWRlJNR2xCSWJpVHZIZlZXd2tGd3VPeDY5T0xZc0ZvaEZHNjBRS1o3UUNOczgtT2I4WUNl?oc=5","date":"2025-11-14","type":"pipeline","source":"BioWorld News","summary":"Invivyd, Emergent and Armata drive infectious disease stock recovery - BioWorld News","headline":"Invivyd, Emergent and Armata drive infectious disease stock recovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPUXZwbXZra2RjVzdtbFRPX2pfX1VWRmZkNVBPQW02cjFWcEtGU1FUVmYzZjRydGw2NG9VSGM4SjlHcldKaW9UMUpydkNUT1l0RlZEeWxuSDhMQzlZQWJ5MUVfNGEtYXZJYUl3UDRyVnNhNnc5S2JjMi14NktJVnU2WlpPYU9oNm5ralFscmVoZzVFWGtTeVkzWXQtMFU2cG1PcmxNd0lRb2x0R2VLZUs5NG9Sdk1NbG5M?oc=5","date":"2025-09-08","type":"regulatory","source":"PMLiVE","summary":"Invivyd working with FDA towards potential Biologics License Application for COVID-19 - PMLiVE","headline":"Invivyd working with FDA towards potential Biologics License Application for COVID-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNSXdfNDZJRjJLM2FpUVlHY0h4dmxIQUd4WU5YUnBzakVNeURBc1FKMGtIR2pQbzNQeFljUWlRZzNtT2pwOHhoTXV3OTFRVzNTcWxXT21GRFlVZzd6amk2MVUxektKM2pVa3VVand4NTdscno0Qk5KTHA2elozQjRBMGlYLTFkUQ?oc=5","date":"2025-08-28","type":"regulatory","source":"statnews.com","summary":"An under-the-radar biotech finds FDA more receptive to an alternative to Covid vaccines - statnews.com","headline":"An under-the-radar biotech finds FDA more receptive to an alternative to Covid vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPdTlrenZYcnZjZHU5N3lOR0xFbDhiaVFnRmw0SllvNDV3d0ZPcDJJM0MtczIzQ3pCVUJLR241bHpudlNNTDVzREluUmw5Z09tWXRNeWJSNFBCRy12MkhkVHUySzMzbmRTeExFQzFrVGRLYm1oTnNEa2VkakJNRF9ERktuWVgwMzVLekJF?oc=5","date":"2025-06-02","type":"regulatory","source":"Pharma Voice","summary":"COVID’s remaining biotech contenders navigate a dwindling market - Pharma Voice","headline":"COVID’s remaining biotech contenders navigate a dwindling market","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_3":3,"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}